Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

248 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adaptive Randomization of Neratinib in Early Breast Cancer.
Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators. Park JW, et al. N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750. N Engl J Med. 2016. PMID: 27406346 Free PMC article. Clinical Trial.
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group. Rebbeck TR, et al. N Engl J Med. 2002 May 23;346(21):1616-22. doi: 10.1056/NEJMoa012158. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023993
A gene-expression signature as a predictor of survival in breast cancer.
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. van de Vijver MJ, et al. N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967. N Engl J Med. 2002. PMID: 12490681
Hard-wired genotype in metastatic breast cancer.
Weigelt B, van't Veer LJ. Weigelt B, et al. Cell Cycle. 2004 Jun;3(6):756-7. doi: 10.4161/cc.3.6.926. Epub 2004 Jun 14. Cell Cycle. 2004. PMID: 15153810 Review.
Gene expression profiling of breast cancer: a new tumor marker.
van't Veer LJ, Paik S, Hayes DF. van't Veer LJ, et al. J Clin Oncol. 2005 Mar 10;23(8):1631-5. doi: 10.1200/JCO.2005.12.005. J Clin Oncol. 2005. PMID: 15755970 Review. No abstract available.
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'.
Lippman ME, Benz C, Chinnaiyan A, Flockhart D, Harris A, Hudis C, Osborne CK, Press MF, Rae J, Sledge GW, Van't Veer L, Wicha M. Lippman ME, et al. Breast Cancer Res Treat. 2005 Mar;90(1):1-3. doi: 10.1007/s10549-004-1288-x. Breast Cancer Res Treat. 2005. PMID: 15770520 No abstract available.
Breast cancer metastasis: markers and models.
Weigelt B, Peterse JL, van 't Veer LJ. Weigelt B, et al. Nat Rev Cancer. 2005 Aug;5(8):591-602. doi: 10.1038/nrc1670. Nat Rev Cancer. 2005. PMID: 16056258 Review.
Concordance among gene-expression-based predictors for breast cancer.
Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM. Fan C, et al. N Engl J Med. 2006 Aug 10;355(6):560-9. doi: 10.1056/NEJMoa052933. N Engl J Med. 2006. PMID: 16899776
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Straver ME, Glas AM, Hannemann J, Wesseling J, van de Vijver MJ, Rutgers EJ, Vrancken Peeters MJ, van Tinteren H, Van't Veer LJ, Rodenhuis S. Straver ME, et al. Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub 2009 Feb 13. Breast Cancer Res Treat. 2010. PMID: 19214742
248 results
Jump to page
Feedback